Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Sylla, Khadime ^a   Tine, Roger Clément Kouly ^a   Ndiaye, Magatte ^a   Sow, Doudou ^a   Sarr, Aïssatou ^a   Mbuyi, Marie Louise Tshibola ^b   Diouf, Ibrahima ^a   Lô, Amy Colé ^a   Abiola, Annie ^a   Seck, Mame Cheikh ^a   Ndiaye, Mouhamadou ^a   Badiane, Aïda Sadikh ^a   N'Diaye, Jean Louis A ^a   Ndiaye, Daouda ^a   Faye, Oumar ^a   Dieng, Thérèse ^a   Dieng, Yémou ^a   Ndir, Oumar ^a   Gaye, Oumar ^a   Faye, Babacar ^a  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

Author keywords

Epidemiology; Malaria; Plasmodium falciparum; Senegal; Serology

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 1; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MICROSCOPY; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; SENEGAL; SEROEPIDEMIOLOGY; SEROLOGY; SEROPREVALENCE; SYMPTOMATOLOGY; BLOOD; IMMUNOLOGY; INFANT; MALARIA, FALCIPARUM; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SENEGAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 84937042257     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0789-x     Document Type: Article

References (41)

1. WHO (2008) Global malaria control and elimination. Technical Consultation Report. Geneva, World Health Organization. http://www.who.int/malaria/publications/atoz/9789241596817/en/
2. WHO (2007) Malaria elimination: A field manual for low and moderate endemic countries. Geneva, World Health Organization. www.who.int/entity/malaria/publications/atoz/9789241596084
3. WHO (2010) WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva, World Health Organization. http://www.who.int/malaria/news/WHO-policy-recommendation-IPTi-032010.pdf?ua=1
4. National malaria control program Senegal (2006) Strategic plan against malaria 2006-2010. http://www.pnlp.sn/rapport.html
5. Mwingira F, Genton B, Kabanywanyi AN, Felger I (2014) Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania. Malar J 13:433
6. Razakandrainibe R, Thonier V, Ratsimbasoa A, Rakotomalala E, Ravaoarisoa E, Raherinjafy R et al (2009) Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programs using serological markers. Acta Trop 111:160-167
7. Rogier C, Henry MC, Trape JF (2009) Evaluation épidémiologique du paludisme en zone d'endémie. Med Trop 69:123-124
8. Rogier C (2003) Paludisme de l'enfant en zone d'endémie: Epidémiologie, Acquisition d'une immunité et Stratégies de lutte. Med Trop 63:449-464
9. Kocken CH, Withers-Martinez C, Dubbeld MA, Van Der WA, Hackett F, Valderrama A et al (2002) High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 70:4471-4476
10. Shimp RL, Martin LB, Zhang Y, Henderson BS, Duggan P et al (2006) Production and characterization of clinical grade Escherichia coli-derived Plasmodium falciparum 42-kDa merozoite surface protein 1 (MSP142) in the absence of an affinity tag. Protein Expr Purif 50:58-67
11. Plassmeyer ML, Reiter K, Shimp RL, Kotova S, Smith PD, Hurt DE et al (2009) Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284: 26951-26963
12. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J et al (2008) Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J 7:195
13. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I et al (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102:5108-5113
14. Guitard J, Cottrell G, Magnouha NM, Salanti A, Li T, Sow S et al (2008) Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum. Malar J 7:10
15. Tine RC, Faye B, Ndour CT, Ndiaye JL, Ndiaye M, Bassene C et al (2011) Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial. Malar J 10:358
16. Dolgin E (2010) Targeting hotspots of transmission promises to reduce malaria. Nat Med 16:1055
17. Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP et al (1997) Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA 94:338-342
18. Oduro AR, Bojang KA, Conway DJ, Corrah T, Greenwood BM, Schellenberg D (2011) Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over time. Plos One 6:26305
19. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R et al (2009) Rapid assessment of malaria transmission using age-specific sero-conversion rates. Plos One 4:6083
20. Agence Nationale de la Statistique et de la Démographie (ANSD), Sénégal, Enquête nationale sur le paludisme 2008-2009 Juillet 2009. http://www.ansd.sn/ressources/rapports/EDS-continue-2008-2009.pdf
21. Agence Nationale de la Statistique et de la Démographie (ANSD), Sénégal. Enquête Démographique et de Santé Continue au Sénégal 2012-2013. http://www.ansd.sn/ressources/rapports/EDS-continue-2012-2013.pdf
22. Oduro RA, Conway DJ, Schellenberg D, Satoguina J, Greenwood BM and Bojang KA (2013) Sero-epidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia. Malar J 12:222
23. Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Filip Claes F et al. (2012) Sero epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J 11:86
24. Tine RT, Ndiaye M, Hansson HH, Ndour CT, Faye B, Alifrangis M et al (2012) The association between malaria parasitaemia, erythrocyte polymorphisms, malnutrition and anaemia in children less than 10 years in Senegal: a case control study. BMC Res Notes 5:565
25. Kwadwo AK, Samuel B, Daniel D, Eric KB, Emmanuel KD, Daniel M et al (2014) Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar J 13:103
26. Supargiyono S, Bretscher MT, Wijayanti MA, Sutanto I, Nugraheni D, Rozqie R et al (2013) Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J 12:444
27. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A et al (2010) Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J 9:169
28. Aguirre A, Lianos CA, Cook J, Contreras MJ, Soto V, Gamboa D et al (2013) Assessing malaria transmission in a low endemiciy area of north-western Peru. Malar J 12:339
29. Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P et al (2008) Cohort study of the association of antibody levels to AMA1, MSP1-19, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J 7:142
30. Boulanger D, Sarr JB, Fillol F, Sokhna C, Cisse B, Schacht A.M et al. (2010) Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children. Malar J 9:363
31. Braga EM, Barros RM, Reis TA, Fontes CJ, Morais CG, Martins MS et al (2002) Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 66:461-466
32. Holder AA, Riley EM (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173:765-769
33. Kitua AY, Lemnge MM, Theander TG (2005) Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission. Malar J 4:48
34. Meraldi V, Nebie I, Tiono AB, Diallo D, Sanogo E, Theisen M et al (2004) Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol 26:265-272
35. Dodoo D, Theisen M, Kurtzhals JA, Akanmori BD, Koram KA, Jepsen S et al (2000) Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J Infect Dis 181:1202-1205
36. Theisen M, Dodoo D, Toure Balde A, Soe S, Corradin G, Koram KK et al (2001) Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun 69:5223-5229
37. Oeuvray C, Theisen M, Rogier C, Trape JF, Jepsen S, Druilhe P (2000) Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infect Immun 68:2617-2620
38. Nahlen BL, Bloland PB, Kaslow DC, Lal AA (1998) A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg 58:211-219
39. Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM (2005) IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol Res 95:420-426
40. Bretscher MT, Supargiyono S, Wijayanti MA, Nugraheni D, Widyastuti AN, Lobo NF et al (2013) Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren. Malar J 12:21
41. Jacklyn W, Hamel MJ, Drakeley CJ, Kariuki S, Shi Y, Lal A et al (2014) Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J 13:451